WNK2 and triple-negative breast carcinoma: A decrease in BTG2 level could indirectly activate AKT and extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathways and regulate the downstream effects of miR-25-3p to stimulate proliferation of triple-negative breast cancer cells [35].